News & Articles

NYU school of medicine becomes the most recent cancer center to join PanFAM-1 prospective study

During the American Association for Cancer Research 2018 Annual Meeting, SelectScience recognized cutting-edge products and technologies advancing life sciences research

The trial demonstrates that first-line pembrolizumab treatment improved overall and progression-free survival rates in patients with metastatic nonsquamous non-small cell lung cancer

The primary endpoint for first-line nivolumab-ipilimumab combo trial indicates improved progression-free survival in patients with advanced non-small cell lung cancer

Expansion of circulating tumor-specific T cells after nivolumab treatment suggests systemic antitumor immunity in patients with resectable lung cancer

The FT819 CAR T cell line has the potential to be mass-produced, stored, and made readily available for cancer immunotherapy

A recent study from University of Edinburgh aims to pinpoint genes that may be associated with depression

MMI launch their latest solution at the AACR meeting in Chicago: CellScan

The latest technologies from ZEISS help doctors advance ophthalmic care with new ways to see pathology and maximize clinical efficiency and performance

Crizotinib yielded a high objective response rate for adult patients with ALK-positive Inflammatory myofibroblastic tumor, and a 100 percent disease control rate